APGE logo

Apogee Therapeutics (APGE) EBIT

annual EBIT:

-$216.87M-$123.87M(-133.19%)
December 31, 2024

Summary

  • As of today (June 18, 2025), APGE annual earnings before interest & taxes is -$216.87 million, with the most recent change of -$123.87 million (-133.19%) on December 31, 2024.
  • During the last 3 years, APGE annual EBIT has fallen by -$186.24 million (-607.92%).
  • APGE annual EBIT is now -607.92% below its all-time high of -$30.64 million, reached on December 31, 2022.

Performance

APGE EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEincome statement metrics

quarterly EBIT:

-$63.10M+$12.79M(+16.85%)
March 31, 2025

Summary

  • As of today (June 18, 2025), APGE quarterly earnings before interest & taxes is -$63.10 million, with the most recent change of +$12.79 million (+16.85%) on March 31, 2025.
  • Over the past year, APGE quarterly EBIT has dropped by -$24.91 million (-65.25%).
  • APGE quarterly EBIT is now -3374.45% below its all-time high of -$1.82 million, reached on June 1, 2022.

Performance

APGE quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEincome statement metrics

TTM EBIT:

-$241.78M-$24.91M(-11.49%)
March 31, 2025

Summary

  • As of today (June 18, 2025), APGE TTM earnings before interest & taxes is -$241.78 million, with the most recent change of -$24.91 million (-11.49%) on March 31, 2025.
  • Over the past year, APGE TTM EBIT has dropped by -$123.26 million (-103.99%).
  • APGE TTM EBIT is now -13214.15% below its all-time high of -$1.82 million, reached on June 1, 2022.

Performance

APGE TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

APGE EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-133.2%-65.3%-104.0%
3 y3 years-607.9%-3374.4%-10000.0%
5 y5 years-607.9%-3374.4%-10000.0%

APGE EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-607.9%at low-3374.4%+16.9%<-9999.0%at low
5 y5-year-607.9%at low-3374.4%+16.9%<-9999.0%at low
alltimeall time-607.9%at low-3374.4%+16.9%<-9999.0%at low

APGE EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$63.10M(-16.8%)
-$241.78M(+11.5%)
Dec 2024
-$216.87M(+133.2%)
-$75.88M(+29.3%)
-$216.87M(+21.7%)
Sep 2024
-
-$58.69M(+33.0%)
-$178.14M(+23.9%)
Jun 2024
-
-$44.12M(+15.6%)
-$143.76M(+21.3%)
Mar 2024
-
-$38.18M(+2.8%)
-$118.53M(+27.4%)
Dec 2023
-$93.00M
-$37.16M(+52.9%)
-$93.00M(+33.1%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$24.30M(+28.7%)
-$69.86M(+24.6%)
Jun 2023
-
-$18.89M(+49.2%)
-$56.06M(+43.8%)
Mar 2023
-
-$12.66M(-9.6%)
-$38.99M(+48.1%)
Dec 2022
-$30.64M
-$14.01M(+33.3%)
-$26.33M(+113.7%)
Sep 2022
-
-$10.51M(+478.6%)
-$12.32M(+578.6%)
Jun 2022
-
-$1.82M
-$1.82M

FAQ

  • What is Apogee Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Apogee Therapeutics?
  • What is Apogee Therapeutics annual EBIT year-on-year change?
  • What is Apogee Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Apogee Therapeutics?
  • What is Apogee Therapeutics quarterly EBIT year-on-year change?
  • What is Apogee Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Apogee Therapeutics?
  • What is Apogee Therapeutics TTM EBIT year-on-year change?

What is Apogee Therapeutics annual earnings before interest & taxes?

The current annual EBIT of APGE is -$216.87M

What is the all time high annual EBIT for Apogee Therapeutics?

Apogee Therapeutics all-time high annual earnings before interest & taxes is -$30.64M

What is Apogee Therapeutics annual EBIT year-on-year change?

Over the past year, APGE annual earnings before interest & taxes has changed by -$123.87M (-133.19%)

What is Apogee Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of APGE is -$63.10M

What is the all time high quarterly EBIT for Apogee Therapeutics?

Apogee Therapeutics all-time high quarterly earnings before interest & taxes is -$1.82M

What is Apogee Therapeutics quarterly EBIT year-on-year change?

Over the past year, APGE quarterly earnings before interest & taxes has changed by -$24.91M (-65.25%)

What is Apogee Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of APGE is -$241.78M

What is the all time high TTM EBIT for Apogee Therapeutics?

Apogee Therapeutics all-time high TTM earnings before interest & taxes is -$1.82M

What is Apogee Therapeutics TTM EBIT year-on-year change?

Over the past year, APGE TTM earnings before interest & taxes has changed by -$123.26M (-103.99%)
On this page